Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05122169Not yet recruiting
Randomised trial of chlorhexidine in surgical site infection (SSI) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Number of participant with episiotomy site infection at 21 days. Planned start Dec 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05122169.